[Interval of action and time of onset and duration of bleeding after the administration of the depot gestagen, 17-alpha-hydroxyprogesterone caproate].
D000077713:17 alpha-Hydroxyprogesterone Caproate; D019326:17-alpha-Hydroxyprogesterone; D002208:Caproates; D005260:Female; D006470:Hemorrhage; D006801:Humans; D006908:Hydroxyprogesterones; D008599:Menstruation Disturbances / Q000628:therapy*; D011374:Progesterone / Q000031:analogs & derivatives; D011372:Progestins
D002208:Caproates; D006908:Hydroxyprogesterones; D011372:Progestins; D000077713:17 alpha-Hydroxyprogesterone Caproate; D011374:Progesterone; D019326:17-alpha-Hydroxyprogesterone
MENSTRUATION DISORDERS/therapy; PROGESTERONE/related compounds
Wirkungserwartung, Zeitpunkt des Eintritts und Dauer der Blutung nach Verabreichung des Depotgestagens 17-alpha-Oxy-Progesteron-Capronat.